This trial is active, not recruiting.

Condition atopic dermatitis
Treatments weekly internet survey, topical triamcinolone
Sponsor Wake Forest University
Start date June 2011
End date October 2016
Trial size 40 participants
Trial identifier NCT01385527, 00016545


The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking double blind (caregiver, investigator, outcomes assessor)
Primary purpose health services research
weekly internet survey
Parents will complete a weekly online survey about medication use.
topical triamcinolone
Topical triamcinolone to all affected areas once daily
(Active Comparator)
topical triamcinolone
Topical triamcinolone to all affected areas once daily

Primary Outcomes

Adherence to topical triamcinolone
time frame: 12 weeks

Secondary Outcomes

Eczema Area Severity Index
time frame: 12 weeks
Investigator's Global Assessment
time frame: 12 weeks

Eligibility Criteria

Male or female participants from 2 years up to 8 years old.

Inclusion Criteria: - Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian. Exclusion Criteria: - Child is less than 2 or greater than 8 years of age. - Known allergy or sensitivity to topical triamcinolone in the child. - Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access. - Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.

Additional Information

Official title Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis
Principal investigator Steven R Feldman, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in May 2016.
Information provided to ClinicalTrials.gov by Wake Forest School of Medicine.